About 200 reports

Neurology Market: A BCC Research Overview Chapter ## Introduction Study Goals and Objectives Reasons for Doing this Study Scope of Report Information Sources Methodology Geographic Breakdown Analyst’s Credentials Chapter ## Summary and Highlights Chapter ## Market and Technology Background Neu

  • Neurology
  • Therapy
  • World
  • Market Shares
  • Market Size

Erenumab is the first and only human monoclonal antibody designed to block the calcitonin gene related peptide receptor.

  • Neurology
  • World
  • AstraZeneca PLC
  • Biogen Idec Inc.
  • Eli Lilly & Co.

Monoclonal antibodies such as mepolizumab and omalizumab are sometimes effective.

  • Cough And Cold
  • China
  • Demand
  • Market Size
  • Trade

Monoclonal antibodies such as mepolizumab and omalizumab are sometimes effective.

  • Cough And Cold
  • China
  • Demand
  • Market Size
  • GlaxoSmithKline plc

Anti-PD-## antibodies target the protein PD-##, which is expressed by immune cells.

  • Cough And Cold
  • HIV AIDS
  • Medical Biotechnology
  • Neurology
  • United States
  • HERPES ZOSTER (SHINGLES) - PIPELINE BY XBIOTECH INC, H2 2019

The company offers monoclonal antibodies treatment for various diseases.

  • Antifungal
  • Cough And Cold
  • Infectious Disease
  • Neurology
  • NanoViricides, Inc.
  • HERPES ZOSTER (SHINGLES) - PIPELINE BY XBIOTECH INC, H1 2018
  • HERPES ZOSTER (SHINGLES) - PIPELINE BY VACCITECH LTD, H1 2018

VACCITECH LTD XBiotech Inc (XBiotech) is a bioscience company that discovers and develops True Human monoclonal antibodies the company provides monoclonal antibodies treatment for various diseases.

  • Infectious Disease
  • Neurology
  • United States
  • Product Initiative
  • GlaxoSmithKline plc

Pasteur Institute NA NA MONOCLONAL ANTIBODY TO ANTAGONIZE FCGRIIA FOR AUTOIMMUNE ARTHRITIS, PULMONARY INFLAMMATION, SYSTEMIC ANAPHYLAXIS AND THROMBOCYTOPENIA - DRUG PROFILE Drug Name Company/ Institute Name Licensed From Company Development Partner Product Description

  • Cough And Cold
  • Therapy
  • United States
  • World
  • Product Initiative

Under the terms of consideration, AstraZeneca gains option rights to IPH##, an antibody targeting CD## monoclonal antibody, as well as four pre-clinical molecules from Innate.

  • Neurology
  • World
  • Company
  • Deals & Alliance
  • AstraZeneca PLC

Avidity' s platform seeks to combine the tissue selectivity of monoclonal antibodies and the precision of oligonucleotide-based therapeutics to potentially overcome barriers to the delivery of oligonucleotides and target genetic drivers of disease.

  • Dermatology
  • Neurology
  • World
  • Company
  • Deals & Alliance

The Center for Drug Evaluation and Research (CDER) oversees chemical-based drugs as well as monoclonal antibodies and cytokines.

  • Biopharmaceutical
  • Neurology
  • Therapy
  • United States
  • Product Initiative
  • 4.1.2 ONCOLOGY - DEALS OF THE YEAR

Under the terms of consideration, AstraZeneca gains option rights to IPH##, an antibody targeting CD## monoclonal antibody, as well as four pre-clinical molecules from Innate.

  • Endocrine Disease
  • Neurology
  • World
  • Company
  • Deals & Alliance

Aimovig is the first and only fully human monoclonal antibody designed to specifically block the calcitonin gene-related peptide (CGRP) receptor; CGRP plays a critical role in migraine activation.

  • Health Services
  • Neurological Disorder
  • Neurology
  • United States
  • Product Initiative

Most recently she served as the Worldwide Brand Director at Novartis Pharmaceuticals Corporation, where she was the global launch lead for Aimovig®, the first monoclonal antibody approved by the U. S.

  • Cough And Cold
  • HIV AIDS
  • Neurology
  • United States
  • AcelRx Pharmaceuticals, Inc.

Syndax also develops SNDX-##, a monoclonal antibody that targets the CSF-## receptor.

  • Cough And Cold
  • Neurology
  • Oncology
  • Pharmaceutical
  • Genentech, Inc.

The drug candidate is a monoclonal antibody that inhibits binding of IL-## to the ST## receptor.

  • Cough And Cold
  • Neurology
  • Therapy
  • United States
  • Product Initiative

The molecules developed by Companies in Pre-Registration, Filing rejected/ Withdrawn, Phase II, Phase I and Preclinical stages are ##, ##, ##, ## and ## respectively.

  • Neurology
  • United States
  • World
  • Product Initiative
  • Alnylam Pharmaceuticals, Inc.

Our VB-## platform comprises classical anti-MOSPD## monoclonal antibodies for inflammatory indications, as well as bi-specific antibody candidates for oncology.

  • Cough And Cold
  • Drug Development
  • Neurology
  • World
  • Product Initiative

Syndax also develops SNDX-##, a monoclonal antibody that targets the CSF-## receptor.

  • Cough And Cold
  • Neurological Disorder
  • Neurology
  • United States
  • UCB S.A.

Trials conducted by companies in Phase II and Phase ## stand at ## and ## respectively.

  • Neurological Disorder
  • Neurology
  • Therapy
  • World
  • Product Initiative

University reported that when anti sema##A antibody is injected to vitreous body of the axotomized eye of animals it did not cause any signs of inflammation, irritation or any other changeswhich may indicate that this treatment is toxic.

  • Neurology
  • Type 2 Diabetes
  • United States
  • Product Initiative
  • Regeneron Pharmaceuticals, Inc.

The two NBE' s are humanized monoclonal therapeutic antibodies.

  • Cough And Cold
  • Healthcare
  • Neurology
  • Pharmaceutical
  • Glenmark Pharmaceuticals Ltd.
  • CLINICAL TRIAL PROFILE SNAPSHOTS

THE PROMINENT FEATURES OF THIS REPORT ARE - ##.

  • Neurology
  • Pharmaceutical
  • World
  • Product Initiative
  • CSL Limited

(HMI), a manufacturer of monoclonal antibodies, for exclusive rights to a human monoclonal IgM antibody that is specific to a cancer cell surface antigen.

  • Cancer
  • Healthcare
  • Neurology
  • Pharmaceutical
  • Morphotek, Inc.

CEMIPLIMAB IS AN INVESTIGATIONAL HUMAN, MONOCLONAL ANTIBODY TARGETING PD-##, BEING JOINTLY DEVELOPED BY SANOFI AND REGENERON.

  • Cough And Cold
  • Neurology
  • Surgery
  • France
  • Western Europe

The treatment was initiated with one injection per month for three consecutive doses, followed by one injection every two months.

  • Neurology
  • Type 2 Diabetes
  • United States
  • Product Initiative
  • Regeneron Pharmaceuticals, Inc.

It also develops a product candidate, an anti-CD## monoclonal antibody that inhibits the production of adenosine produced by the tumor cells.

  • Cough And Cold
  • Neurology
  • Pharmaceutical
  • United States
  • Vernalis plc

(Merck) to provide Merck access to one of Xencor' s Fc engineering patents for a therapeutic monoclonal antibody.

  • Cough And Cold
  • Neurology
  • United States
  • Company
  • Xencor, Inc.

As per the agreement, Innate Pharma is comparing the production of its monoclonal antibody in EBx and CHO cells.

  • Cough And Cold
  • Immunology
  • Neurology
  • Pharmaceutical
  • Vivalis SA
  • PERIPHERAL NEUROPATHY (SENSORY NEUROPATHY) - PIPELINE BY GENEURO SA, H2 2016

GNbAC-## is a humanized monoclonal antibody of immunoglobulin G## type.

  • Neurology
  • Type 2 Diabetes
  • United States
  • World
  • Product Initiative